Descripción de la empresa
Horizon Technology Finance Corporation operates as a business development company dedicated to providing secured debt and venture lending investments to development-stage companies within the technology, life science, and healthcare information sectors. Although specific sector and industry classifications are not publicly disclosed for this entity, its operational model focuses on financing ventures backed by venture capital, distinguishing it from traditional commercial lending by targeting earlier-stage growth opportunities. The company's scale is defined by a trailing twelve-month revenue of $108.44 million, while the market capitalization and employee count are currently not available in public filings. These financial figures indicate a mid-sized financial institution operating within a niche segment of the capital markets, where revenue generation is the primary metric for assessing operational footprint in the absence of broader valuation data such as market cap or headcount.
Salud financiera
The company reported a trailing twelve-month revenue of $108.44 million against a net income loss of $2,505,000, revealing a significant divergence between top-line growth and bottom-line profitability that points to substantial cost structures or one-time charges impacting the bottom line. While the EBITDA figure is not disclosed in the current reporting period, the reported free cash flow stands at $34.32 million, indicating that the company generates sufficient liquidity from operations to cover capital expenditures and debt obligations despite the reported net loss. The gross margin is recorded at 100.0%, a characteristic typical of business development companies that act as conduits for debt rather than manufacturers of physical goods, while the operating margin of 84.6% suggests high efficiency in managing administrative expenses before interest and taxes. However, the profit margin stands at -2.3%, reflecting the impact of interest expenses or other non-operating costs that erode the operating surplus. In terms of liquidity and leverage, the company holds $34.82 million in cash against a total debt load of $435.50 million, resulting in a debt-to-equity ratio of 125.66 which characterizes a highly leveraged balance sheet typical for this business model. The current ratio of 3.41 demonstrates a robust short-term liquidity position, suggesting the company can easily meet its current liabilities with its current assets. Furthermore, the return on equity is -0.8% while the return on assets is 7.2%, a disparity that reveals management is effectively utilizing assets to generate earnings before interest and taxes, yet the high leverage and interest burdens prevent the translation of asset returns into equityholder value.
Evaluación de valoración
The trailing twelve-month P/E ratio is 21.01, whereas the forward P/E ratio is not available, implying that the market currently values the stock based on historical earnings rather than projected future profitability due to the reported net loss. The price-to-book ratio stands at 2.47, indicating that the market price is trading at a significant premium relative to the company's book value of equity, which often reflects investor expectations of future growth or the intangible value of the portfolio. Since the price-to-sales ratio and EV/EBITDA are not available in the current data, alternative valuation metrics must be interpreted through the lens of the existing P/E and P/B figures to assess relative cheapness or expensiveness. The stock has traded between a 52-week low of $24.60 and a 52-week high of $26.61, meaning the current trading price resides within a relatively narrow band near the upper end of its recent trading range. The beta of 1.17 indicates that the stock exhibits higher price volatility than the broader market, moving approximately 17% more than the market average in response to systemic factors.
Growth & Income
Revenue growth for the trailing twelve months is 25.3%, demonstrating a strong expansion in the top line, while earnings growth is not applicable due to the reported net loss. This divergence suggests that the company is prioritizing portfolio expansion and asset acquisition over immediate profitability, a common strategy in business development companies during growth phases. Since the company does not pay a dividend, evidenced by the absence of a dividend yield and payout ratio, it reinvests all available earnings and free cash flow directly into new lending opportunities and portfolio growth rather than distributing income to shareholders. The overall growth profile is characterized by aggressive top-line expansion supported by strong free cash flow generation, while the income profile is currently non-existent for shareholders due to the lack of dividend payments and negative net income.